Hikma Pharmaceuticals PLC (HIK.L) LSE

1,567.00

+29(+1.89%)

Updated at January 14 04:35PM

Currency In GBp

Valuation

Market Cap5.56B
Enterprise Value6.68B
P/E Ratio12.61
PEG Ratio0
Price/Sales Ratio1.44
Price/Book Ratio1.87
Enterprise/Revenue1.85
Enterprise/EBITDA10.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.16

Management Effectiveness

Return On Assets0.07
Return On Equity0.15

Income Statement

Revenue3.13B
Revenue/Share14.42
Gross Profit1.42B
EBITDA787M
Net Income359M
Diluted EPS1.61

Balance Sheet

Total Cash236M
Total Cash/Share1.06
Total Debt1.55B
Total Debt/Equity0.62
Current Ratio1.24
Book Value Per Share11.44

Price History

52-Week Change-22.13
52-Week High2,360
52-Week Low1,482
Moving Average 50 Days1,563.5
Moving Average 200 Days1,814.62

Statistics

Average Volume752,186
Shares Outstanding220.73M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0.86
Trailing Annual Dividend Yield4.08
Payout Ratio0.48
Last Split FactorN/A
Last Split DateN/A